Benitec Biopharma Inc. Patent Applications Pending
3 applications still open at the USPTO, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.
- 2025-12-23: Application 19496897; Invention DEVICE AND METHODS FOR ADMINISTERING A THERAPEUTIC COMPOSITION TO THE PHARYNGEAL MUSCLE; Applicant Benitec IP Holdings Inc.; Status Application Undergoing Preexam Processing.
- 2023-06-28: Application 63510750; Invention DEVICE AND METHODS FOR ADMINISTERING A THERAPEUTIC COMPOSITION TO THE PHARYNGEAL MUSCLE; Applicant Benitec IP Holdings Inc.; Status Provisional Application Expired.
- 2021-08-27: Application 17434666; Invention Compositions and Methods for Treating Oculopharyngeal Muscular Dystrophy (OPMD); Applicant Benitec IP Holdings Inc.; Status Publications -- Issue Fee Payment Verified.
| Filed | Application | Invention | Applicant | Status | Published as | Inventor name | Inventor country | Examiner |
|---|---|---|---|---|---|---|---|---|
| 2025-12-23 | 19496897 | DEVICE AND METHODS FOR ADMINISTERING A THERAPEUTIC COMPOSITION TO THE PHARYNGEAL MUSCLE | Benitec IP Holdings Inc. | Application Undergoing Preexam Processing | Sophie Mukadam Jerel Banks Jean Lacau St-guily | United States United States United States | ||
| 2023-06-28 | 63510750 | DEVICE AND METHODS FOR ADMINISTERING A THERAPEUTIC COMPOSITION TO THE PHARYNGEAL MUSCLE | Benitec IP Holdings Inc. | Provisional Application Expired | Sophie Mukadam Jerel Banks Jean Lacau St-Guily | United States United States France | ||
| 2021-08-27 | 17434666 | Compositions and Methods for Treating Oculopharyngeal Muscular Dystrophy (OPMD) | Benitec IP Holdings Inc. | Publications -- Issue Fee Payment Verified | US20220098614A1 | Vanessa Strings-Ufombah David Suhy Shih-Chu Kao Petrus W. Roelvink | United States United States United States United States | WHITEMAN, BRIAN A |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |
| Emergent BioSolutions Inc. (EBS) | United States | $0.347B | -2.43 |
| ENANTA PHARMACEUTICALS INC (ENTA) | United States | $0.349B | -6.72 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |